Joinn Laboratories (China) Co Ltd

603127

Company Profile

  • Business description

    Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.

  • Contact

    A5 Rongjing East Street
    Beijing Economic-Technological Development Area
    Beijing100176
    CHN

    T: +86 1067869966

    https://www.joinnlabs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2024

    Employees

    2,510

Stocks News & Analysis

stocks

Best and worst performing ASX sectors of 2024

Exploring the ASX sectors that moved the market this year.
stocks

2 ASX companies with the traits of a long-term winner

Two companies that show promising signs of handsomely rewarding shareholders.
video

Our outlook for 2025

Morningstar Equity Market Strategist Lochlan Halloway discusses his view on what we can expect in markets in 2025. 

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,471.5018.800.22%
CAC 407,282.6910.370.14%
DAX 4019,848.7735.98-0.18%
Dow JONES (US)43,297.03390.080.91%
FTSE 1008,136.9934.270.42%
HKSE20,098.29215.161.08%
NASDAQ20,031.13266.241.35%
Nikkei 22539,568.06437.631.12%
NZX 50 Index13,074.7486.710.67%
S&P 5006,040.0465.971.10%
S&P/ASX 2008,220.9019.300.24%
SSE Composite Index3,393.5342.271.26%

Market Movers